Challenges of Geriatric Oncology

  • Lodovico Balducci


The management of cancer in the older person is an increasingly common problem, as 60% of all neoplasms occur in individuals age 65 and older [1]. Aging is associated with a progressive decline in life-expectancy, functional reserve, and social resources, and an increased prevalence of comorbidity [2]. This process is highly individualised and poorly reflected in chronologic age. The diversity of the older population affects both clinical practice and clinical research, and underlies the main challenges of geriatric oncology. These include the formulation of individual treatment plans and of research protocols.


Endometrial Cancer Clin Oncol Cytotoxic Chemotherapy Geriatric Assessment Functional Reserve 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yancik R, Ries LA (2000) Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin N America 14:17–23CrossRefGoogle Scholar
  2. 2.
    Balducci L, Extermann M (2004) A practical approach to the older cancer patient. Curr Probl Cancer 25:6–76Google Scholar
  3. 3.
    Balducci L, Extermann M (2003) The assessment of the older cancer patient. In: Overcash J, Balducci L (eds) The older cancer Patient. Springer medical Publisher, New YorkGoogle Scholar
  4. 4.
    Cohen HJ, Feussner JR, Weinberger M et al (2002) A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 346:905–912PubMedCrossRefGoogle Scholar
  5. 5.
    Bernabei R, Gambassi G, Carbonin P (2002) A controlled trial of geriatric evaluation. N Engl J Med 347:371–373PubMedCrossRefGoogle Scholar
  6. 6.
    Extermann M (2003) Comprehensive geriatric Assessment basics for the cancer professional. J Oncol Manag 12:13–17PubMedGoogle Scholar
  7. 7.
    Repetto L, Fratino L, Audisio RA et al (2002) Comprehensive geriatric assessment adds information to the Eastern Cooperative group performance status in elderly cancer patients. An Italian group for geriatric oncology study. J Clin Oncol 20:494–502PubMedCrossRefGoogle Scholar
  8. 8.
    Ingram SS, Seo PH, Martell RE et al (2002) Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol 20:770–775PubMedCrossRefGoogle Scholar
  9. 9.
    Extermann M, Overcash J, Lyman GH et al (1998) Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16:1582–1587PubMedGoogle Scholar
  10. 10.
    Balducci L, Yates J (2006) Guidelines for the management of older patients with cancer. Oncology, NCCN Proceedings, November, pp 221–227Google Scholar
  11. 11.
    Cohen HJ, Harris T, Pieper CF (2003) Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 114:180–187PubMedCrossRefGoogle Scholar
  12. 12.
    Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J gerontol med Sci 56A:M146–M156Google Scholar
  13. 13.
    Extermann M, Chan H, Cantor AB et al (2002) Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J canceer 38:1466–1473CrossRefGoogle Scholar
  14. 14.
    Chen H, Cantor A, Meyer J et al (2003) Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer 97:1107–1114Google Scholar
  15. 15.
    Balducci L (2003) Anemia, cancer and aging. Cancer Control JHLMCC 10:478–486Google Scholar
  16. 16.
    Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 116(Suppl 7A): 11s–26sPubMedCrossRefGoogle Scholar
  17. 17.
    Blazer DG, Hybels CF, Pieper CF (2001) The association of depression and mortality in elderly persons: a case for multiple independent pathways. J gerontol Med Sci 56A:M505–M509Google Scholar
  18. 18.
    Garman KS, Pieper Cf, Seo P et al (2003) Function in elderly cancer survivors depends on comorbidity. J gerontol Med Sci 58:M1119–M1124Google Scholar
  19. 19.
    Hewitt M, Rowland JH, Yancik R (2003) Cancer survivors in the United States: age health and disability. J Gerontol Med Sci 58:82–91Google Scholar
  20. 20.
    Walter LC, Brand RJ, Counsell SR et al (2001) Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 285:2750–2756PubMedCrossRefGoogle Scholar
  21. 21.
    Walter LC, Covinsky KE (2001) Cancer Screening in elderly patients, JAMA 285:2750–2756PubMedCrossRefGoogle Scholar
  22. 22.
    Lipsitz LA (2004) Physiolocical complexity, aging and the path to frailty. Sci Aging Knowledge Environ (16) PE16Google Scholar
  23. 23.
    Wingo PA, Guest JL, McGinnis L et al (2000) Patterns of inpatient surgeries for the top four cancers in the United States. Cancer Causes Control 11:497–512PubMedCrossRefGoogle Scholar
  24. 24.
    Fabri P (2005) Cancer surgery in the elderly. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive geriatric oncology, 2nd ed. Taylor & Francis, New York, pp 399–405Google Scholar
  25. 25.
    Olmi P, Ausili Cefaro GP, Balzi M et al (1997) Radiotherapy in the aged. Clin Ger Med 13:143–168Google Scholar
  26. 26.
    Scalliet P, Pignon T (1998) Radiotherapy in the elderly. In: Balducci L, Lyman GH, Ershler WB (ed) Comprehensive geriatric oncology, Harwood Academic Publishers, Amsterdam, pp 421–428Google Scholar
  27. 27.
    Zachariah B, Balducci L (2000) Radiation therapy of the older patient. Hematol Oncol Clin N America 14:131–167CrossRefGoogle Scholar
  28. 28.
    Cova D, Balducci L (2005) Cancer chemotherapy in the older patient. In: Balducci L, Lyman GH, Ershler WB (eds), Comprehensive geriatric oncology, 2nd ed. Taylor & Francis, New York, pp 463–488Google Scholar
  29. 29.
    Marx GM, Blake GM, Galani E et al (2004) Evaluation of the Cockroft-Gault Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Ann Oncol 15:291–295PubMedCrossRefGoogle Scholar
  30. 30.
    Balducci L, Repetto L (2004) Increased risk of myelotoxicity in elderly patients with non-Hodgkin’s Lymphoma. Cancer 100:6–11PubMedCrossRefGoogle Scholar
  31. 31.
    Zinzani PL, Storti S, Zaccaria A et al (1999) Elderly aggressive-histology non-Hodgkin’s lymphoma: firstline VNCOP-B regimen experience on 350 patients. Blood 94:33–38PubMedGoogle Scholar
  32. 32.
    Zagonel V, Babare R, Merola MC et al (1994) Costbenefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin’s lymphoma treated with combination chemotherapy. Ann Oncol 5(Suppl 2):127–132PubMedGoogle Scholar
  33. 33.
    Bertini M (1993) Therapeutic strategies in intermediate grade lymphomas in elderly patients. The Italian Multiregional non Hodgkin’s Lymphoma Study Group (IMRNHLSG). Hematol Oncol 11(Suppl 1):52–58PubMedGoogle Scholar
  34. 34.
    Osby E, Hagberg H, Kvaloy S et al; Nordic Lymphoma Group (2003) CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. Blood 101:3840–3848Google Scholar
  35. 35.
    Doorduijn JK, van der Holt B, van Imhoff GW et al (2003) CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin’s lymphoma. J Clin Oncol 21:3041–3050PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2006

Authors and Affiliations

  • Lodovico Balducci
    • 1
  1. 1.H. Lee Moffitt Cancer Center & Research Institute Senior Adult Community ProgramTampaUSA

Personalised recommendations